ARCHIVES

Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 6 | June 26, 2009

Download PDF Visit The Full Archive

Related Articles

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978